- Location
biologics research
"-
Immunocore Entered Into an Oncology Collaboration and Licensing Agreement with MedImmune
Jan 9, 2014Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, today announced that it has entered into an oncology research collaboration and licensing agreement with ...
Tags: Immunocore, oncology research, collaboration and licensing agreement
-
BioWa and Lonza Have Entered Into a Licensing Agreement with MedImmune
Dec 13, 2013BioWa, a wholly owned subsidiary of Kyowa Hakko Kirin, and Lonza, a biotechnology company, have entered into a licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca. MedImmune has licensed ...
-
The European Commission Has Granted Marketing Authorisation
Dec 10, 2013The European Commission (EC) has granted marketing authorisation for AstraZeneca's new four-in-one influenza vaccine Fluenz Tetra for the prevention of influenza in children and adolescents from 24 months up to 18 years of age. The ...
Tags: Chronic Hepatitis, Medicine
-
Unilife Has Announced an Agreement with Medimmunefor Use in Medimmune's Pipeline
Nov 14, 2013Unilife, a US based manufacturer of injectable drug delivery systems, has announced an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to customize and supply devices from its platform of wearable ...
-
AstraZeneca's Global Biologics Research Division Medimmune Will Acquire Spirogen
Oct 18, 2013AstraZeneca's global biologics research and development division MedImmune will acquire Spirogen, a biotech firm focused on antibody-drug conjugate technology for use in oncology. Spirogen's complete shares will be purchased by MedImmune ...
Tags: biologics research, AstraZeneca